| 11.1°C Belfast

Video: Heart attack and stroke patients in UK called on to take part in global study


Heart attack and stroke patients in UK called on to take part in global study to reduce risk of secondary attack or stroke • A new global study called FOURIER, sponsored by the pharmaceutical company Amgen, and supported by the Imperial Clinical Trials Unit has been launched in the UK (also taking place across Europe, US, Canada, Australia, Asia and Latin America) • The study aims to establish whether a new class of drug can reduce the risk of heart attacks or strokes in people who have already had a heart attack, a stroke or have peripheral arterial disease • The study is expected to last 5 years and will investigate whether taking this new type of cholesterol lowering treatment, on top of a statin will reduce the risk of major cardiovascular events compared to just taking statin therapy www.imperial.ac.uk/clinicaltrialsunit/cu­rrenttrials Credit: www.imperial.ac.uk

 

Most Watched Videos

Privacy